Emovi
KneeKG is the first in-clinic device to enable doctors to accurately assess the knee in 3D while moving/weight-bearing
KneeKG is the first in-clinic device to enable doctors to accurately assess the knee in 3D while moving/weight-bearing
Emovi, pioneering advanced knee joint assessment to enhance patients' quality of life, is driven by a passionate and innovative healthcare team. The company, established in 2007, offers advanced medical solutions for joint assessments with a focus on knee joint evaluations aimed at restoring patient quality of life. Emovi prides itself on its top-quality, innovative products and features a dedicated team that is committed to advancing healthcare. The latest investment of $50.00K came in the form of a grant investment on 22 April 2022 from The Arthritis Society. This injection of funds from The Arthritis Society emphasizes the potential and value seen in Emovi's contributions to advancing knee joint assessments and healthcare.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $50.00K | 1 |
|
22 Apr 2022 |
| Series C | $15.00M | 3 |
|
04 Mar 2019 |
| Angel Round | Unknown | 1 |
|
01 Jun 2007 |
No recent news or press coverage available for Emovi.
We care about your data, and we'd love to use cookies make your experience better.
